Abstract
Growing evidence suggests that neuropeptide Y (NPY) plays an important role in the immune system. NPY is produced by the central and peripheral nervous system but also by immune cells in response to activation. NPY has pleiotropic effects on both the innate and adaptive arms of the immune system, with effects ranging from the modulation of cell migration to macrophage, T helper (Th) cell cytokine release, and antibody production. Subsequent studies have confirmed the importance of this system in immunity in particular via the demonstration that Y1, a receptor for NPY, plays a fundamental role in autoimmunity and inflammation using Y1-deficient animals. Furthermore, clinical studies have suggested a role for NPY in other immune disorders such as asthma and arthritis. This review provides the latest information on the role of NPY and Y1 in the immune system, and discusses the potential new opportunities of this work for the development of a new generation of immuno-modulatory treatments of autoimmune and inflammatory diseases.
Keywords: Neuropeptide Y, Y receptors, immunity, autoimmunity, inflammation, asthma
Current Topics in Medicinal Chemistry
Title: NPY and Receptors in Immune and Inflammatory Diseases
Volume: 7 Issue: 17
Author(s): Julie Wheway, Herbert Herzog and Fabienne Mackay
Affiliation:
Keywords: Neuropeptide Y, Y receptors, immunity, autoimmunity, inflammation, asthma
Abstract: Growing evidence suggests that neuropeptide Y (NPY) plays an important role in the immune system. NPY is produced by the central and peripheral nervous system but also by immune cells in response to activation. NPY has pleiotropic effects on both the innate and adaptive arms of the immune system, with effects ranging from the modulation of cell migration to macrophage, T helper (Th) cell cytokine release, and antibody production. Subsequent studies have confirmed the importance of this system in immunity in particular via the demonstration that Y1, a receptor for NPY, plays a fundamental role in autoimmunity and inflammation using Y1-deficient animals. Furthermore, clinical studies have suggested a role for NPY in other immune disorders such as asthma and arthritis. This review provides the latest information on the role of NPY and Y1 in the immune system, and discusses the potential new opportunities of this work for the development of a new generation of immuno-modulatory treatments of autoimmune and inflammatory diseases.
Export Options
About this article
Cite this article as:
Wheway Julie, Herzog Herbert and Mackay Fabienne, NPY and Receptors in Immune and Inflammatory Diseases, Current Topics in Medicinal Chemistry 2007; 7 (17) . https://dx.doi.org/10.2174/156802607782341046
DOI https://dx.doi.org/10.2174/156802607782341046 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bispidine as a Privileged Scaffold
Current Topics in Medicinal Chemistry Antifungal Proteins: Potent Candidate for Inhibition of Pathogenic Fungi
Current Bioactive Compounds Meet Our Editorial Board Member
Current Proteomics Proteome Analysis of Resting Human Neutrophils
Protein & Peptide Letters Hypertension in Hemodialysis Patients
Current Hypertension Reviews Molecules to Selectively Target Receptors for Treatment of Pain and Neurogenic Inflammation
Recent Patents on Inflammation & Allergy Drug Discovery Cationic Surfactants and Lipids as Anti-Infective Agents
Anti-Infective Agents in Medicinal Chemistry Oral Corticosteroid Use in Exacerbations of Asthma
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) SARS-CoV-2: Molecular Biology and Therapeutic Targets
Coronaviruses Effector Cells and Downstream Mediators in Severe Cutaneous Adverse Reactions
Current Immunology Reviews (Discontinued) Cysteine Network (CYSTEINET) Dysregulation in Parkinson’s Disease: Role of N-acetylcysteine
Current Drug Metabolism Fractions of <i>Boswellia Serrata</i> Suppress LTA<sub>4</sub>, LTC<sub>4</sub>, Cyclooxygenase-2 Activities and mRNA in HL-60 Cells and Reduce Lung Inflammation in BALB/c Mice
Current Drug Discovery Technologies Novel Strategies for the Treatment of Allergy
Recent Patents on Inflammation & Allergy Drug Discovery Mass Spectrometric Analysis of F2-Isoprostanes: Markers and Mediators in Human Disease
Current Pharmaceutical Analysis Natural Compounds with Proteasome Inhibitory Activity for Cancer Prevention and Treatment
Current Protein & Peptide Science Patient Perspectives in OMERACT Provide an Anchor for Future Metric Development and Improved Approaches to Healthcare Delivery in Connective Tissue Disease Related Interstitial Lung Disease (CTD-ILD)
Current Respiratory Medicine Reviews Targeted Drug Delivery Systems for Lung Macrophages
Current Drug Targets Cytokines in Human Breast Milk: Immunological Significance for Newborns
Current Nutrition & Food Science Editorial [Hot Topic: Modulation and New Mediators in Inflammation Executive (Guest Editor: Frank A. Redegeld)]
Current Pharmaceutical Design Cysteinyl Leukotrienes (CysLTs): Role in Obesity-Induced Asthma
Current Molecular Medicine